Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,015 | 287 | 99.6% |
| Education | $17.62 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,140 | 90 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $630.67 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $502.22 | 26 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $309.25 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $231.31 | 12 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $214.72 | 13 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $171.61 | 8 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $167.42 | 7 | $0 (2024) |
| EISAI INC. | $167.13 | 4 | $0 (2022) |
| UROVANT SCIENCES INC | $159.43 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $626.66 | 28 | Teva Pharmaceuticals USA, Inc. ($149.07) |
| 2023 | $738.26 | 41 | Sumitomo Pharma America, Inc. ($193.49) |
| 2022 | $814.58 | 43 | Sunovion Pharmaceuticals Inc. ($257.51) |
| 2021 | $362.22 | 16 | Eisai Inc. ($132.64) |
| 2020 | $231.71 | 19 | Sunovion Pharmaceuticals Inc. ($205.81) |
| 2019 | $700.35 | 47 | Sunovion Pharmaceuticals Inc. ($291.67) |
| 2018 | $882.30 | 58 | ACADIA Pharmaceuticals Inc ($249.08) |
| 2017 | $676.76 | 39 | ACADIA Pharmaceuticals Inc ($215.61) |
All Payment Transactions
291 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: HIV | ||||||
| 11/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Central Nervous System | ||||||
| 07/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: HIV | ||||||
| 06/19/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Neurology | ||||||
| 05/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: PSYCHIATRY | ||||||
| 05/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Central Nervous System | ||||||
| 05/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Gastroenterology | ||||||
| 04/30/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Central Nervous System | ||||||
| 04/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Cardio-renal | ||||||
| 04/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: PSYCHIATRY | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Central Nervous System | ||||||
| 03/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $67.64 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 944 | 2,236 | $316,365 | $199,483 |
| 2022 | 8 | 1,119 | 2,172 | $320,740 | $192,248 |
| 2021 | 11 | 1,442 | 2,430 | $362,775 | $228,164 |
| 2020 | 10 | 1,792 | 3,125 | $446,310 | $265,857 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 171 | 723 | $97,605 | $64,622 | 66.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 339 | 402 | $80,400 | $60,825 | 75.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 244 | 786 | $98,250 | $48,874 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 211 | $27,430 | $17,419 | 63.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 64 | 65 | $7,975 | $4,425 | 55.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 12 | 13 | $2,275 | $1,493 | 65.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $770.00 | $754.60 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $1,330 | $747.94 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $330.00 | $323.40 | 98.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 504 | 583 | $116,600 | $81,891 | 70.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 256 | 706 | $88,250 | $41,648 | 47.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 146 | 521 | $70,335 | $41,285 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 217 | $28,210 | $18,133 | 64.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 94 | 96 | $12,000 | $6,915 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 16 | $1,520 | $889.78 | 58.5% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 13 | 20 | $2,200 | $746.96 | 34.0% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Office | 2022 | 13 | 13 | $1,625 | $739.90 | 45.5% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2021 | 641 | 735 | $147,000 | $106,582 | 72.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 182 | 525 | $70,875 | $42,045 | 59.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 240 | 589 | $73,625 | $35,857 | 48.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 237 | $30,810 | $20,303 | 65.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 183 | 190 | $23,700 | $14,411 | 60.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 17 | 29 | $5,075 | $3,090 | 60.9% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 36 | 55 | $6,050 | $2,131 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 25 | $2,375 | $1,550 | 65.3% |
About Dr. Mitul Dave, MD
Dr. Mitul Dave, MD is a Internal Medicine healthcare provider based in Ellicott City, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396833604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitul Dave, MD has received a total of $5,033 in payments from pharmaceutical and medical device companies, with $626.66 received in 2024. These payments were reported across 291 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($5,015).
As a Medicare-enrolled provider, Dave has provided services to 5,297 Medicare beneficiaries, totaling 9,963 services with total Medicare billing of $885,752. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Ellicott City, MD
- Active Since 10/11/2006
- Last Updated 04/24/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396833604
Products in Payments
- APTIOM (Drug) $1,052
- NUPLAZID (Drug) $630.67
- XARELTO (Drug) $407.74
- ENTRESTO (Drug) $292.92
- GEMTESA (Drug) $231.60
- REXULTI (Drug) $203.09
- ZENPEP (Drug) $201.20
- Austedo XR (Drug) $200.56
- LONHALA MAGNAIR (Drug) $182.07
- GVOKE PFS (Drug) $126.53
- NUEDEXTA (Drug) $126.12
- Dayvigo (Drug) $121.00
- VALTOCO (Drug) $83.71
- INVOKANA (Drug) $58.83
- LOKELMA (Drug) $51.68
- XIFAXAN (Drug) $47.29
- Fycompa (Drug) $46.13
- BAQSIMI (Drug) $45.55
- GVOKE HYPOPEN (Drug) $45.08
- HYSINGLA ER (Drug) $43.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ellicott City
Dr. Linda Lang, Md, MD
Internal Medicine — Payments: $13,993
Dr. Steven Eversley, M.d, M.D
Internal Medicine — Payments: $11,661
Parry Moore, M.d, M.D
Internal Medicine — Payments: $9,787
Jagdeep Singh, M.d, M.D
Internal Medicine — Payments: $9,538
Nikolay Tchopev, M.d, M.D
Internal Medicine — Payments: $8,806
Dr. Warren Ross, M.d, M.D
Internal Medicine — Payments: $7,600